Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference4 articles.
1. Leuchs A, Zinserling J, Brandt A, Wirtz D, Benda N. Choosing appropriate estimands in clinical trials [published online February 17, 2015]. Therapeutic Innovation & Regulatory Science. doi: https://doi.org/10.1177/2168479014567317.
2. O’Kelly M, Berry S, Walp D, Garrett A. Lifecycle modeling and simulation: current practice and future impact on healthcare innovation and delivery. Therapeutic Innovation & Regulatory Science. 2013;47(2):175–182.
3. International Conference on Harmonisation. ICH harmonised tripartite guideline: general considerations for clinical trials: E8. 1997. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E8/Step4/E8_Guideline.pdf. Accessed March 2015.
4. Fritsch K. Multiplicity issues in FDA-reviewed clinical trials. Presented at: EMA Workshop on Multiplicity Issues in Clinical Trials; November 16, 2012; London, UK. http://www.ema.europa.eu/docs/en_GB/document_library/Presentation/2013/03/WC500140627.pdf. Accessed March 2015.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献